Effects of High-Intensity Interval Running Versus Cycling on Sclerostin, and Markers of Bone Turnover and Oxidative Stress in Young Men
- 44 Downloads
This study compared sclerostin’s response to impact versus no-impact high-intensity interval exercise in young men and examined the association between exercise-induced changes in sclerostin and markers of bone turnover and oxidative stress. Twenty healthy men (22.3 ± 2.3 years) performed two high-intensity interval exercise trials (crossover design); running on treadmill and cycling on cycle ergometer. Trials consisted of eight 1 min running or cycling intervals at ≥ 90% of maximal heart rate, separated by 1 min passive recovery intervals. Blood samples were collected at rest (pre-exercise), and 5 min, 1 h, 24 h, and 48 h following each trial. Serum levels of sclerostin, cross-linked telopeptide of type I collagen (CTXI), procollagen type I amino-terminal propeptide (PINP), thiobarbituric acid reactive substances (TBARS), and protein carbonyls (PC) were measured. There was no significant time or exercise mode effect for PINP and PC. A significant time effect was found for sclerostin, CTXI, and TBARS with no significant exercise mode effect and no significant time-by-mode interaction. Sclerostin increased from pre- to 5 min post-exercise (47%, p < 0.05) and returned to baseline within 1 h following the exercise. CTXI increased from pre- to 5 min post-exercise (28%, p < 0.05), then gradually returned to baseline by 48 h. TBARS did not increase significantly from pre- to 5 min post-exercise but significantly decreased from 5 min to 48 h post-exercise. There were no significant correlations between exercise-induced changes in sclerostin and any other marker. In young men, sclerostin’s response to high-intensity interval exercise is independent of impact and is not related to changes in bone turnover and oxidative stress markers.
KeywordsExercise Sclerostin Bone turnover Oxidative stress
This study was funded by the National Sciences and Engineering Research Council of Canada (NSERC) grant to P. Klentrou (grant # 2015-04424). R. Kouvelioti holds an Ontario Trillium Scholarship. W. Ward holds a Canada Research Chair in Bone and Muscle Development. The authors would like to thank the participants for participating in this study, all volunteers for their assistance in different parts of the study (D. Brown, R. Sweeney, M. Nasato, A. Theocharidis, S. Pilakka, D. Szkaradek), the phlebotomists (especially C. Watt), and lab coordinators (R. Dotan, J. Gabrie) for their guidance.
RK designed the study, completed all data collection, and prepared the first draft of the paper. PL contributed to the analysis of blood samples. BF, WEW, and ARJ contributed to the experimental design and the interpretation of the data. PK was the supervisor of the research and contributed to the experimental design, data analysis, and interpretation of the data. She is the guarantor. All authors revised the paper critically for intellectual content and approved the final version. All authors agree to be accountable for the work and to ensure that any questions relating to the accuracy and integrity of the paper are investigated and properly resolved.
Compliance with Ethical Standards
Conflict of interest
R. Kouvelioti, P. LeBlanc, B. Falk, W.E. Ward, A.R. Josse and P. Klentrou have no conflict of interest to declare.
Human and Animal Rights and Informed Consent
The study was conducted in accordance with the Declaration of Helsinki and received ethics approval from our institutional Research Ethics Board (File # 16-016). All participants agreed to participate in this study by signing a consent form.
- 8.Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak heinrich J, Bellido TM, Harris SE, Turner CH (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of sost/sclerostin. J Biol Chem 283:5866–5875. https://doi.org/10.1074/jbc.M705092200 CrossRefGoogle Scholar
- 11.Gombos GC, Bajsz V, Pék E, Schmidt B, Sió E, Molics B, Betlehem J (2016) Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass. BMC Musculoskelet Disord 17:254. https://doi.org/10.1186/s12891-016-1109-5 CrossRefGoogle Scholar
- 14.Durosier C, van Lierop A, Ferrari S, Chevalley T, Papapoulos S, Rizzoli R (2013) Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women. J Clin Endocrinol Metab 98:3873–3883. https://doi.org/10.1210/jc.2013-2113 CrossRefGoogle Scholar
- 15.Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico RA, Pulvirenti I, Hawa G, Tringali G, Fiore CE (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95:2248–2253. https://doi.org/10.1210/jc.2010-0067 CrossRefGoogle Scholar
- 19.Kang J, Boonanantanasarn K, Baek K, Woo KM, Ryoo H-M, Baek J h, Kim G-S (2015) Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner. J Periodontal Implant Sci 45:101. https://doi.org/10.5051/jpis.2015.45.3.101 CrossRefGoogle Scholar
- 24.Borg GA (1973) Perceived exertion: a note on “history” and methods. Med Sci Sports 5:90–93Google Scholar
- 31.Weinstein Y, Bediz C, Dotan R, Falk B (1998) Reliability of peak-lactate, heart rate, and plasma volume following the Wingate test. Med Sci Sports Exerc 30:1456–1460Google Scholar
- 35.de Oliveira Teixeira A, Franco OS, Borges MM, Martins CN, Guerreiro LF, da Rosa CE, da Silva Paulitsch F, Perez W, da Silva AM, Signori LU (2014) The importance of adjustments for changes in plasma volume in the interpretation of hematological and inflammatory responses after resistance exercise. J Exerc Physiol 17:72–83Google Scholar
- 38.Dekker J, Nelson K, Kurgan N, Falk B, Josse A, Klentrou P (2017) Wnt signaling–related osteokines and transforming growth factors before and after a single bout of plyometric exercise in child and adolescent females. Pediatr Exerc Sci 29:504–512. https://doi.org/10.1123/pes.2017-0042 CrossRefGoogle Scholar
- 41.Farquhar B, Kenney W (1997) Anti-inflamatory drugs, kidney function, and exercise. Sport Sci Exch 11:1–6Google Scholar
- 43.Fulzele K, Lai F, Dedic C, Saini V, Uda Y, Shi C, Tuck P, Aronson JL, Liu X, Spatz JM, Wein MN, Divieti Pajevic P (2017) Osteocyte-secreted Wnt signaling inhibitor sclerostin contributes to beige adipogenesis in peripheral fat depots. J Bone Miner Res 32:373–384. https://doi.org/10.1002/jbmr.3001 CrossRefGoogle Scholar
- 44.Morgan AL, Weiss J, Kelley ET (2015) Bone turnover response to acute exercise with varying impact levels: a preliminary investigation. Int J Exerc Sci 8:154–163Google Scholar
- 45.Ardawi M-SM, Rouzi AA, Qari MH (2012) Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study. J Clin Endocrinol Metab 97:3691–3699. https://doi.org/10.1210/jc.2011-3361 CrossRefGoogle Scholar
- 47.Gaeini AA, Rahnama N, Hamedinia MR (2006) Effects of vitamin E supplementation on oxidative stress at rest and after exercise to exhaustion in athletic students. J Sports Med Phys Fitness 46:458–461Google Scholar
- 51.Veskoukis AS, Nikolaidis MG, Kyparos A, Kouretas D (2009) Blood reflects tissue oxidative stress depending on biomarker and tissue studied. Free Radic Biol Med 47:1371–1374. https://doi.org/10.1016/J.FREERADBIOMED.2009.07.014 CrossRefGoogle Scholar